For following the competition: what moved in each program, several studies read as one move.
- ianalumab
- dazodalibep
- deucravacitinib
- + 21 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Sjogren's Syndrome to watchlistEvery Monday by email · turn it off any timePro · free during the beta